Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001193125-26-447171

Chief Financial Officer sold 6,582 shares at $2.05 ($13,525)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Adawi Kamal Chief Financial Officer 2026-11-03 Sale −6,582 $2.05 $13,525 93,418 D
Open-market sales · 6,582 sh · avg $2.05 · $13,525
Loading xslF345X06/ownership.xml…